The Patent Finder

Envirologix Inc.

16 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

1
Ending by 2030
Aug 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 4, 2027
    The maintenance fee for Compositions and methods for quantifying a nucleic acid sequence in a sample comprising a primer oligonucleotide with a 3′-terminal region comprising a 2′-modified nucleotide (US 9,096,897) comes due Feb 4, 2027. Unpaid by Aug 4, 2027, it lapses early.
  • 1 fee due Jul 9, 2027
    The maintenance fee for Isolated oligonucleotides containing modified nucleotides (US 11,866,773) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
  • 1 fee due Aug 25, 2027
    The maintenance fee for Compositions and Methods for Detecting Nicking Enzyme and Polymerase Activity Using a Substrate Molecule (US 10,570,441) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
  • 1 fee due Sep 10, 2027
    The maintenance fee for Compositions and methods for detecting a nucleic acid sequence in a sample comprising a primer oligonucleotide with a 3′-terminal region comprising a 2′-modified nucleotide (US 10,584,376) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.
  • 1 fee due Oct 26, 2027
    The maintenance fee for Compositions and methods for monitoring in real time a nicking amplification reaction comprising a primer oligonucleotide with a 3′—terminal region comprising A2′—modified nucleotide (US 9,322,053) comes due Oct 26, 2027. Unpaid by Apr 26, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,824,800Immunoassay analysis method
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,096,897Compositions and methods for quantifying a nucleic acid sequence in a sample comprising a primer oligonucleotide with a 3′-terminal region comprising a 2′-modified nucleotide
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,322,053Compositions and methods for monitoring in real time a nicking amplification reaction comprising a primer oligonucleotide with a 3′—terminal region comprising A2′—modified nucleotide
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,631,231Compositions and methods for amplifying a nucleic acid sequence comprising a primer oligonucleotide with a 3′-terminal region comprising a 2′-modified nucleotide
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,077,467Compositions and methods for detecting a nucleic acid sequence in a sample comprising a primer oligonucleotide with a 3′-terminal region comprising a 2′-modified nucleotide
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,584,376Compositions and methods for detecting a nucleic acid sequence in a sample comprising a primer oligonucleotide with a 3′-terminal region comprising a 2′-modified nucleotide
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
US 11,208,687Compositions and methods for quantifying a nucleic acid sequence in a sample
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,866,773Isolated oligonucleotides containing modified nucleotides
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,043,866Compositions and methods for quantifying a nucleic acid sequence in a sample
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,258,637Compositions and methods for enhancing and/or predicting DNA amplification
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
Also on record, not counted in the 16: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited